Latest Administration News

Saferoads Holdings Limited is initiating a buy-back of unmarketable share parcels under $500, offering shareholders a simple, cost-free exit at $0.10 per share. Shareholders must opt out by 30 April to retain their holdings.

Telix Pharmaceuticals has resubmitted its New Drug Application to the FDA for TLX101-Px (Pixclara®), aiming to advance a novel PET imaging agent for glioma diagnosis. The resubmission addresses prior regulatory concerns with additional data, reinforcing hopes for expedited approval.

Tetratherix Limited launches a new precision medicine franchise leveraging its Tetramatrix™ platform, securing a decade-long exclusive partnership with US health group Superpower Health Inc. This deal promises immediate revenue and complements ongoing FDA milestones.

WAM Active Limited has updated its Dividend Reinvestment Plan rules, allowing residual dividend balances to be carried forward and aligning the plan with current market practices. These changes aim to enhance shareholder participation and capital management.

Argo Investments Limited has confirmed a fully franked dividend of AUD 0.185 per share for the half-year ending December 2025, alongside updated details on its Dividend Reinvestment Plan and Bonus Security Plan pricing.

Asian Battery Metals has exercised its option to acquire the Maikhan Uul Copper-Gold Project in southwestern Mongolia, adding a strategically significant asset to its portfolio with confirmed high-grade mineralisation and a long-term mining licence.

TasFoods Limited has appointed KPMG as voluntary administrators following the unsuccessful sale of its Nichols Poultry business, signalling a critical restructuring phase. A creditors' meeting is scheduled for 23 March 2026 as the company seeks new capital or buyers.

Acrux Limited has secured a $0.55 million advance on its FY26 R&D Tax Incentive, providing crucial funding to accelerate development of its Hormone Replacement Therapy following FDA regulatory confirmation.

Imugene Limited has launched a $20 million capital raising through a $12 million institutional placement and an $8 million Share Purchase Plan, alongside a convertible notes amendment to support its clinical development pipeline.

WA Kaolin Limited has responded to ASX queries clarifying that its Q2 FY2026 order book was a demand snapshot, not a sales forecast, and confirmed timely disclosure of a production shortfall linked to plant issues. The company also addressed regulatory notices, affirming no material impact on operations or securities value.

Argo Global Listed Infrastructure Limited has announced a fully franked dividend of AUD 0.045 per share for the half-year ending December 2025, alongside updated Dividend Reinvestment and Substitution Share Plan prices.

Lendlease Group has updated its dividend announcement, confirming the Dividend Reinvestment Plan price and detailing dividend amounts in Australian, New Zealand, and British currencies.